The New FDA-Product Approval Conference

The US Food and Drug Administration has recently released information about its new strategies as a result of the new administration.

The new commissioner recently announced a new policy for Warning Letters and FDA-483 responses, putting manufacturers under very tight response timelines.

Areas Covered in the seminar:

• The "new" FDA organization and mission
• Enforcement changes- increased inspection
• Enforcement Changes-new expectations
• Manufacturers responsibilities for FDA-483s
• Manufacturers responsibilities in Warning Letter situations
• Pre-market changes-Human Factors
• New Risk Management Guidance

Who Will Benefit:

• Regulatory Managers
• Quality Managers
• Product Managers
• Project Managers

Contact Detail:

Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: [email protected]
http://www.compliance4all.com/
Event Link : http://www.compliance4all.com/control/w_product/~product_id=501066LIVE?channel=mailer&camp=Webinar&AdGroup=govevents_Jan_2017_SEO
Twitter Follow us – https://twitter.com/compliance4all
Facebook Like us – https://www.facebook.com/Compliance4all
LinkedIn Like us – https://www.linkedin.com/company/compliance4all